Tocilizumab in Patients With Giant Cell Arteritis: Results From a Phase 3 Randomized Controlled Trial (video)

Update Item Information
Identifier 20170403_nanos_sciplatform1_01-video
Title Tocilizumab in Patients With Giant Cell Arteritis: Results From a Phase 3 Randomized Controlled Trial (video)
Creator Susan Mollan, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Neil Collinson, John Stone
Subject Vascular disorders, Neuro-ophth & systyemic disease ( eg. MS, MG, thyroid), Optic neuropathy
Description The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in patients with giant cell arteritis (GCA) in GiACTA, a randomized, double-blind, placebo-controlled trial.1 Data for week 52 outcome measures are presented.
Date 2017
Language eng
Format video/mp4
Source 2017 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2017: Scientific Platform I
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6gj3crx
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Susan Mollan
Contributor Secondary Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Neil Collinson, John Stone
Setname ehsl_novel_nam
ID 1277729
Reference URL https://collections.lib.utah.edu/ark:/87278/s6gj3crx
Back to Search Results